Wed, Mar 4, 2015, 7:59 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • usagary1 usagary1 Apr 15, 2013 1:55 PM Flag

    THIS IS WHAT I THINK ABOUT SAREPTA'S DMD DRUG ALONG WITH A PLATFORM APPROVAL

    FIRST ,Eteplirsen should be called eteplirsen-51 for exon 51 approval and then as the platform progresses eteplirsen -50 then eteplirsen-45 ,you can see where i am going here.This is the same drug no matter what exon it is. ''just a sequence change per exon'' A early approval for the first exon would be correct based on the super benefit and the fantastic safety profile the the pmo-s have had for many years.You can approve Sarepta's drugs with a safety follow up on these boys every month if need be.Never have i seen a druh like this that does so much and causes so little harm.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
14.06+0.70(+5.24%)Mar 4 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Wayfair Inc.
NYSEWed, Mar 4, 2015 4:02 PM EST
Veeva Systems Inc.
NYSEWed, Mar 4, 2015 4:02 PM EST